[1]
L. Manenschijn and P. Hamberg, “Prolonged biochemical response after discontinuation of orteronel (TAK-700) in a patient with metastasized castration-resistant prostate cancer”, AO, vol. 55, no. 5, pp. 656–658, May 2016.